Race and Vision Outcomes in Ranibizumab-Treated Participants With Diabetic Macular Edema: A Meta-Analysis

• Published in: JAMA ophthalmology Vol. 143; no. 6; p. 455
• Main Authors: Khan, M Ali, Hill, Lauren, Stoilov, Ivaylo, Haller, Julia A
• Format: Journal Article
• Language: English
• Published: United States 01.06.2025
• Subjects: Angiogenesis Inhibitors - therapeutic use; Black or African American - statistics & numerical data; Diabetic Retinopathy - drug therapy; Diabetic Retinopathy - ethnology; Diabetic Retinopathy - physiopathology; Female; Humans; Intravitreal Injections; Laser Coagulation; Macular Edema - drug therapy; Macular Edema - ethnology; Macular Edema - physiopathology; Male; Randomized Controlled Trials as Topic; Ranibizumab - therapeutic use; Treatment Outcome; Vascular Endothelial Growth Factor A - antagonists & inhibitors; Visual Acuity - physiology; White People - statistics & numerical data

Vision outcomes in response to anti-vascular endothelial growth factor therapy for diabetic macular edema (DME) may differ between races. This meta-analysis investigated whether vision outcomes differed among racial subgroups treated with ranibizumab for DME in a clinical trial setting. To assess th...